| 000 | 01837 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250512200021.0 | ||
| 264 | 0 | _c19830909 | |
| 008 | 198309s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(83)90288-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarrell, M J | |
| 245 | 0 | 0 |
_aAn economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cAug 1983 |
||
| 300 |
_a301-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRabies _xprevention & control |
| 650 | 0 | 4 |
_aRabies Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aRabies virus _ximmunology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aVaccination _xeconomics |
| 700 | 1 | _aWarrell, D A | |
| 700 | 1 | _aSuntharasamai, P | |
| 700 | 1 | _aViravan, C | |
| 700 | 1 | _aSinhaseni, A | |
| 700 | 1 | _aUdomsakdi, D | |
| 700 | 1 | _aPhanfung, R | |
| 700 | 1 | _aXueref, C | |
| 700 | 1 | _aVincent-Falquet, J C | |
| 700 | 1 | _aNicholson, K G | |
| 700 | 1 | _aBunnag, D | |
| 700 | 1 | _aHarinasuta, T | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8345 _gp. 301-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(83)90288-x _zAvailable from publisher's website |
| 999 |
_c6135910 _d6135910 |
||